Immunosuppressive therapy and post-transplant malignancy

Nephrol Dial Transplant. 2009 Apr;24(4):1097-103. doi: 10.1093/ndt/gfn605. Epub 2008 Oct 31.

Authors

Sophie Domhan¹, Martin Zeier, Amir Abdollahi

Affiliation

¹ Department of Medicine, Center of Cancer Systems Biology, Caritas St. Elizabeth's Medical Center, Tufts University, 736 Cambridge Street, CBR1, Boston, MA 02135, USA. Sophie.Domhan@Tufts.edu

PMID: 18978068
DOI: 10.1093/ndt/gfn605

No abstract available

MeSH terms

Azathioprine / adverse effects
Azathioprine / pharmacology
Calcineurin Inhibitors
Fingolimod Hydrochloride
Humans
Immunosuppressive Agents / adverse effects*
Immunosuppressive Agents / pharmacology
Mycophenolic Acid / adverse effects
Mycophenolic Acid / pharmacology
Neoplasms / chemically induced
Neoplasms / etiology*
Neoplasms / immunology
Organ Transplantation* / adverse effects
Propylene Glycols / adverse effects
Propylene Glycols / pharmacology
Protein Kinases / physiology
Sphingosine / adverse effects
Sphingosine / analogs & derivatives
Sphingosine / pharmacology
TOR Serine-Threonine Kinases

Substances

Calcineurin Inhibitors
Immunosuppressive Agents
Propylene Glycols
Protein Kinases
MTOR protein, human
TOR Serine-Threonine Kinases
Fingolimod Hydrochloride
Mycophenolic Acid
Azathioprine
Sphingosine